KZ
Kazia Therapeutics Ltd ADR
KZIA · NASDAQ
$9.44 -12.51% (-$1.35)
1M -20.81%
Market Cap $24.2M
P/E Ratio -
Div. Yield -
ROE 340.84%
Bulios Fair Price
$7.62
19.3% downside
Trenutna cena
$9.44
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KZIA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 576.87x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 61.34%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 49,290.50%
Op. margin 33,850.00%
Quality
40 /100
Average ROIC 172.61%
ROE 340.84%
ROA 341.56%
Debt
0 /100
High Current ratio 0.35x
Debt/Equity N/A
Int. coverage N/A
Stability
19 /100
Unstable Beta 2.15x
Rev. volatility 240,092.36%
EPS volatility 33.25%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KZIA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Friend
Employees
6
Headquarters
Sydney
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report